- Report
- November 2023
- 150 Pages
Global
From €4719EUR$4,850USD£4,043GBP
- Report
- January 2022
- 40 Pages
India
From €2525EUR$2,595USD£2,163GBP
- Report
- January 2022
- 40 Pages
Saudi Arabia
From €2525EUR$2,595USD£2,163GBP
- Report
- January 2020
- 100 Pages
Global
From €4665EUR$4,795USD£3,997GBP
- Report
- January 2022
- 80 Pages
Africa
From €3692EUR$3,795USD£3,163GBP
- Report
- January 2022
- 40 Pages
Brazil
From €2525EUR$2,595USD£2,163GBP
- Report
- January 2022
- 40 Pages
China
From €2525EUR$2,595USD£2,163GBP
- Report
- January 2022
- 40 Pages
France
From €2525EUR$2,595USD£2,163GBP
- Report
- January 2022
- 40 Pages
Germany
From €2525EUR$2,595USD£2,163GBP
- Report
- January 2022
- 40 Pages
Ireland
From €2525EUR$2,595USD£2,163GBP
- Report
- January 2022
- 40 Pages
Japan
From €2525EUR$2,595USD£2,163GBP
- Report
- January 2022
- 40 Pages
Russia
From €2525EUR$2,595USD£2,163GBP
- Report
- January 2022
- 40 Pages
South Korea
From €2525EUR$2,595USD£2,163GBP
- Report
- January 2022
- 40 Pages
United States
From €2525EUR$2,595USD£2,163GBP
- Report
- January 2022
- 40 Pages
Vietnam
From €2525EUR$2,595USD£2,163GBP
- Report
- December 2019
- 222 Pages
Global
From €5225EUR$5,370USD£4,476GBP
Calcium Channel Blocker Vasodilators are a class of cardiovascular drugs used to treat hypertension, angina, and other cardiovascular conditions. These drugs work by blocking the entry of calcium ions into the cells of the heart and blood vessels, which relaxes the muscles of the vessels and reduces blood pressure. They also reduce the workload of the heart by decreasing the amount of oxygen needed to pump blood. Common side effects of these drugs include dizziness, headache, and nausea.
Calcium Channel Blocker Vasodilators are available in both oral and intravenous forms. Oral forms are typically taken once or twice daily, while intravenous forms are administered as needed. These drugs are often used in combination with other medications, such as diuretics, beta-blockers, and ACE inhibitors, to achieve optimal blood pressure control.
Some companies that produce Calcium Channel Blocker Vasodilators include Pfizer, Merck, and Novartis. Show Less Read more